Table of Content

1 Key Insights

2 West Syndrome Overview at a Glance

3 Executive Summary of West Syndrome

4 West Syndrome: Disease Background and Overview
4.1 Introduction
4.2 Metabolic etiologies in West syndrome
4.3 Etiology-specific Subtypes of West syndrome
4.4 Causes and Risk Factors
4.5 Clinical Manifestations
4.6 Symptoms
4.7 Pathophysiology
4.8 Diagnosis
4.9 Differential Diagnosis
4.10 Prognosis

5 Diagnostic Algorithm for West Syndrome

6 Clinical Algorithm for Epileptic Spasms (Infantile Spasms) By Texas Children’s Hospital

7 Epidemiology and Patient Population
7.1 Key Findings
7.2 7MM Total Prevalent Population of West Syndrome
7.3 7MM Total Diagnosed Prevalent Population of West Syndrome

8 Country Wise-Epidemiology of West Syndrome
8.1 Assumptions and Rationale: 7MM Countries
8.2 United States
8.2.1 Assumptions and Rationale
8.2.2 Total Prevalent Population of West Syndrome in the United States
8.2.3 Total Diagnosed Prevalent Population of West Syndrome in the United States
8.2.4 Gender-specific Diagnosed Prevalent Population of West Syndrome in the United States
8.3 EU5 Countries
8.3.1 Assumptions and Rationale
8.4 Germany
8.4.1 Total Prevalent Population of West Syndrome in Germany
8.4.2 Total Diagnosed Prevalent Population of West Syndrome in Germany
8.4.3 Gender-specific Diagnosed Prevalent Population of West Syndrome in Germany
8.5 France
8.5.1 Total Prevalent Population of West Syndrome in France
8.5.2 Total Diagnosed Prevalent Population of West Syndrome in France
8.5.3 Gender-specific Diagnosed Prevalent Population of West Syndrome in France
8.6 Italy
8.6.1 Total Prevalent Population of West Syndrome in Italy
8.6.2 Total Diagnosed Prevalent Population of West Syndrome in Italy
8.6.3 Gender-specific Diagnosed Prevalent Population of West Syndrome in Italy
8.7 Spain
8.7.1 Total Prevalent Population of West Syndrome in Spain
8.7.2 Total Diagnosed Prevalent Population of West Syndrome in Spain
8.7.3 Gender-specific Diagnosed Prevalent Population of West Syndrome in Spain
8.8 United Kingdom
8.8.1 Total Prevalent Population of West Syndrome in the United Kingdom
8.8.2 Total Diagnosed Prevalent Population of West Syndrome in the United Kingdom
8.8.3 Gender-specific Diagnosed Prevalent Population of West Syndrome in the United Kingdom
8.9 Japan
8.9.1 Assumptions and Rationale
8.9.2 Total Prevalent Population of West Syndrome in Japan
8.9.3 Total Diagnosed Prevalent Population of West Syndrome in Japan
8.9.4 Gender-specific Diagnosed Prevalent Population of West Syndrome in Japan

9 Appendix
9.1 Bibliography
9.2 Report Methodology

10 DelveInsight Capabilities

11 Disclaimer

12 About DelveInsight



List of Figures


Figure 1: Key Causes of West Syndrome
Figure 2: Symptoms of West Syndrome
Figure 3: Main characteristic symptoms of West Syndrome
Figure 4: Diagnostic Algorithm for West Syndrome
Figure 5: Clinical Algorithm for Epileptic Spasms (Infantile Spasms)
Figure 6: Total Prevalent Population of West Syndrome in the 7MM (2017–2030)
Figure 7: Total Diagnosed Prevalent Population of West Syndrome in the 7MM (2017–2030)
Figure 8: Total Prevalent Population of West Syndrome in the United States (2017–2030)
Figure 9: Total Diagnosed Prevalent Population of West Syndrome in the United States (2017–2030)
Figure 10: Gender-specific Diagnosed Prevalent Population of West Syndrome in the US (2017–2030)
Figure 11: Total Prevalent Population of West Syndrome in Germany (2017–2030)
Figure 12: Total Diagnosed Prevalent Population of West Syndrome in Germany (2017–2030)
Figure 13: Gender-specific Diagnosed Prevalent Population of West Syndrome in Germany (2017–2030)
Figure 14: Total Prevalent Population of West Syndrome in France (2017–2030)
Figure 15: Total Diagnosed Prevalent Population of West Syndrome in France (2017–2030)
Figure 16: Gender-specific Diagnosed Prevalent Population of West Syndrome in France (2017–2030)
Figure 17: Total Prevalent Population of West Syndrome in Italy (2017–2030)
Figure 18: Total Diagnosed Prevalent Population of West Syndrome in Italy (2017–2030)
Figure 19: Gender-specific Diagnosed Prevalent Population of West Syndrome in Italy (2017–2030)
Figure 20: Total Prevalent Population of West Syndrome in Spain (2017–2030)
Figure 21: Total Diagnosed Prevalent Population of West Syndrome in Spain (2017–2030)
Figure 22: Gender-specific Diagnosed Prevalent Population of West Syndrome in Spain (2017–2030)
Figure 23: Total Prevalent Population of West Syndrome in the United Kingdom (2017–2030)
Figure 24: Total Diagnosed Prevalent Population of West Syndrome in the United Kingdom (2017–2030)
Figure 25: Gender-specific Diagnosed Prevalent Population of West Syndrome in the UK (2017–2030)
Figure 26: Total Prevalent Population of West Syndrome in Japan (2017–2030)
Figure 27: Total Diagnosed Prevalent Population of West Syndrome in Japan (2017–2030)
Figure 28: Gender-specific Diagnosed Prevalent Population of West Syndrome in Japan (2017–2030)


List of Tables


Table 1: Summary of West Syndrome, Epidemiology and Key Events (2017–2030)
Table 2: Metabolic etiologies in Infantile Spasms
Table 3: Proportion of occurrence of different symptoms in West Syndrome patients
Table 4: Examinations to be conducted for West Syndrome
Table 5: Differential Diagnosis for Infantile spasms
Table 6: Total Prevalent Population of West Syndrome in the 7MM (2017–2030)
Table 7: Total Diagnosed Prevalent Population of West Syndrome in the 7MM (2017–2030)
Table 8: Total Prevalent Population of West Syndrome in the United States (2017–2030)
Table 9: Total Diagnosed Prevalent Population of West Syndrome in the United States (2017–2030)
Table 10: Gender-specific Diagnosed Prevalent Population of West Syndrome in the United States (2017–2030)
Table 11: Total Prevalent Population of West Syndrome in Germany (2017–2030)
Table 12: Total Diagnosed Prevalent Population of West Syndrome in Germany (2017–2030)
Table 13: Gender-specific Diagnosed Prevalent Population of West Syndrome in Germany (2017–2030)
Table 14: Total Prevalent Population of West Syndrome in France (2017–2030)
Table 15: Total Diagnosed Prevalent Population of West Syndrome in France (2017–2030)
Table 16: Gender-specific Diagnosed Prevalent Population of West Syndrome in France (2017–2030)
Table 17: Total Prevalent Population of West Syndrome in Italy (2017–2030)
Table 18: Total Diagnosed Prevalent Population of West Syndrome in Italy (2017–2030)
Table 19: Gender-specific Diagnosed Prevalent Population of West Syndrome in Italy (2017–2030)
Table 20: Total Prevalent Population of West Syndrome in Spain (2017–2030)
Table 21: Total Diagnosed Prevalent Population of West Syndrome in Spain (2017–2030)
Table 22: Gender-specific Diagnosed Prevalent Population of West Syndrome in Spain (2017–2030)
Table 23: Total Prevalent Population of West Syndrome in the United Kingdom (2017–2030)
Table 24: Total Diagnosed Prevalent Population of West Syndrome in the United Kingdom (2017–2030)
Table 25: Gender-specific Diagnosed Prevalent Population of West Syndrome in the United Kingdom (2017–2030)
Table 26: Total Prevalent Population of West Syndrome in the Japan (2017–2030)
Table 27: Total Diagnosed Prevalent Population of West Syndrome in Japan (2017–2030)
Table 28: Gender-specific Diagnosed Prevalent Population of West Syndrome in Japan (2017–2030)